• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

作者信息

Hillman A L, Eisenberg J M, Pauly M V, Bloom B S, Glick H, Kinosian B, Schwartz J S

出版信息

N Engl J Med. 1991 May 9;324(19):1362-5. doi: 10.1056/NEJM199105093241911.

DOI:10.1056/NEJM199105093241911
PMID:1901959
Abstract
摘要

相似文献

1
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.避免制药公司资助的成本效益研究在实施和报告过程中出现偏差。
N Engl J Med. 1991 May 9;324(19):1362-5. doi: 10.1056/NEJM199105093241911.
2
Academe, government, and the pharmaceutical industry: a tripod of necessity.
Prog Clin Biol Res. 1983;128:27-34.
3
Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.规避行业资助研究中的法律和道德陷阱：制药行业中研究、学术与营销的共存。
Food Drug Law J. 2004;59(4):595-615.
4
The role of pharmaceutical companies in sponsored research.制药公司在赞助研究中的作用。
Ophthalmology. 2007 Jun;114(6):1037-8. doi: 10.1016/j.ophtha.2007.02.027.
5
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
6
Minimizing bias in industry-sponsored outcomes research.尽量减少行业资助的结果研究中的偏差。
Med Interface. 1994 Apr;7(4):130-4.
7
Medical-legal analysis and considerations in product liability cases involving pharmaceutical companies.
Leg Med. 1989:125-43.
8
Commercial support and bias in pharmaceutical research.
Am J Med. 2004 Dec 1;117(11):876-8. doi: 10.1016/j.amjmed.2004.10.001.
9
Physicians' interactions with pharmaceutical companies.
Pediatrics. 1992 Aug;90(2 Pt 1):281-2.
10
Pharmaceutical research: cost savings through innovation.药物研究：通过创新实现成本节约。
AAPPO J. 1993 Oct;3(5):28-36.

引用本文的文献

1
Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis.可重复性研究实践、健康经济评估中的开放性和透明度：一项横断面比较分析的研究方案。
BMJ Open. 2020 Feb 13;10(2):e034463. doi: 10.1136/bmjopen-2019-034463.
2
Ethical development of stem-cell-based interventions.基于干细胞的干预措施的伦理发展。
Nat Med. 2019 Jul;25(7):1037-1044. doi: 10.1038/s41591-019-0511-6. Epub 2019 Jul 3.
3
[Potential sponsorship bias in cost-effectiveness analyses of healthcare interventions: A cross-sectional analysis].
[医疗保健干预措施成本效益分析中的潜在赞助偏差：一项横断面分析]
Aten Primaria. 2017 Jun-Jul;49(6):335-342. doi: 10.1016/j.aprim.2016.08.001. Epub 2017 Jan 3.
4
Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.经济评估研究是否为伊朗有效的医疗资源分配提供了信息？文献综述。
Cost Eff Resour Alloc. 2014 Jul 11;12:15. doi: 10.1186/1478-7547-12-15. eCollection 2014.
5
A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco products.对烟草行业提交的反对烟草制品标准化包装的证据的数量、相关性和质量进行的批判性评估。
BMJ Open. 2014 Feb 12;4(2):e003757. doi: 10.1136/bmjopen-2013-003757.
6
When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.何时他汀类药物在心血管预防方面具有成本效益？他汀类药物经济学评价中的赞助偏见和结论的系统评价。
PLoS One. 2013 Jul 8;8(7):e69462. doi: 10.1371/journal.pone.0069462. Print 2013.
7
Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.喹硫平：在双相情感障碍中的药物经济学评价。
Pharmacoeconomics. 2012 Jul 1;30(7):611-31. doi: 10.2165/11208500-000000000-00000.
8
Drugs, money and society (Part II).毒品、金钱与社会（第二部分）。
Br J Clin Pharmacol. 2010 Sep;70(3):342-5. doi: 10.1111/j.1365-2125.2009.03569.x.
9
Transparency of economic evaluations of health technologies.卫生技术经济评估的透明度。
Pharmacoeconomics. 2008;26(3):181-3. doi: 10.2165/00019053-200826030-00002.
10
Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.经济评估在药品管理委员会的决策中起作用吗？一项定性研究。
Pharm World Sci. 2007 Dec;29(6):661-70. doi: 10.1007/s11096-007-9125-z. Epub 2007 Jun 14.